Design Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$12.24

-0.57 (-4.45%)

As of Sep 20, 10:23 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +381.6% upside

Low Target $40.84

Average Target $58.95

High Target $77.34

Current Price $12.24

Current
$12.24

Target
$58.95

$40.84 $58.95 avg $77.34

Scenario Analysis

Bear Case

$40.84

233.7%

Low target

Base Case

$58.95

+381.6%

Avg target

Bull Case

$77.34

+531.9%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$17.25

-29.0% from high

52-Week Low

$5.28

+131.8% from low

Target vs 52W High

$58.95

+241.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.6%
AMGN Amgen Inc	Hold	43	47%	$190.87	-51.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+140.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.2%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-13.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%